| Agent(s) | Authors | RR | SD | Toxicities |
| Sorafenib | Matei et al. | 2/59 partial | 20/59 | Rash, GI, cardiovascular, metabolic, pulmonary | Sorafenib + bevacizumab | Azad et al. | 6/13 partial | | HTN, diarrhea, HFS, thrombocytopenia, proteinuria, fistula | Sorafenib + gemcitabine | Welch et al. | 6/18 partial | 10/18 | Lymphopenia, thrombocytopenia, HTN, HFS, pain, neutropenia, hypokalemia | Imatinib | Coleman et al. | 0/12 | 4/12 | Fatigue, nausea/vomiting, rash, neutropenia | Imatinib | Alberts et al. | 0/19 | | Hematologic, metabolic | Imatinib | Schilder et al. | 1/56 complete | | Neutropenia, GI, dermatologic, pain, electrolyte disturbances |
|
|